Skip to content

Transversus Abdominis Plane Block for Chronic Postsurgical Orchalgia

Transversus Abdominis Plane Block for Chronic Postsurgical Orchalgia: SHAM Controlled, Randomized Trial, Three Months Results

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03525938
Enrollment
70
Registered
2018-05-16
Start date
2018-05-10
Completion date
2019-11-25
Last updated
2019-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Post-surgical Pain

Brief summary

the study will evaluate the effect of transversus abdominis plane block (TAP) on chronic post-groin surgeries orchalgia (chronic testicular pain)

Interventions

PROCEDURETAP block

Whilst the patient is in the supine position, a high frequency ultrasound probe (10 MH) is placed transverse to the abdominal wall between the costal margin and iliac crest. The needle is introduced in plane of the ultrasound probe directly under the probe and advanced until it reaches the plane between the internal oblique and transversus abdominis muscles. Upon reaching the plane, 2 ml of saline is injected to confirm correct needle position after which 20 ml of levobupivacaine, 25% plus triamcinolone, 80 mg solution is injected for TAP group and 20 ml of saline only is injected for SHAM group.. The transversus abdominis plane is visualized expanding with the injection ( appears as a hypoechoic space)

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* The inclusion criteria were patients with chronic scrotal pain (orchialgia) that fulfilled the following criteria: 1. pain intensity ≥ 5 on the visual analog scale (VAS), 2. pain that lasted for more than 3 months after groin surgeries, 3. failed conservative treatment with nonsteroidal anti-inflammatory drugs (NSAIDs)

Exclusion criteria

* The

Design outcomes

Primary

MeasureTime frameDescription
The change of intensity of pain measured by Visual Analogue Pain (VAS ) scoreThe pain assessment will be done one month, 2 month and 3 month postprocedure.The Visual Analogue Pain (VAS) scale is a tool for intensity of pain scored from 0 to 10, where 0 = no pain and 10 = the worst pain imaginable

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026